Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
54.96
+0.65 (1.20%)
At close: Nov 19, 2025
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of $87.68 billion as of November 24, 2025. Its market cap has increased by 3.92% in one year.
Market Cap
87.68B
Enterprise Value
82.05B
Revenue
8.20B
Ranking
n/a
PE Ratio
32.67
Stock Price
$54.96
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 2.50B to 87.68B, an increase of 3,405.84%. That is a compound annual growth rate of 11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 87.88B | 19.92% |
| Dec 30, 2024 | 73.28B | 17.53% |
| Dec 29, 2023 | 62.35B | 48.41% |
| Dec 30, 2022 | 42.01B | -21.23% |
| Dec 30, 2021 | 53.34B | -39.09% |
| Dec 30, 2020 | 87.57B | 72.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 555.46M |
| Glass House Brands | 520.88M |
| Tian'an Technology Group | 386.45M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 382.71M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |